Back
Range Cancer Therapeutics ETF Vs. First Trust Nasdaq Pharmaceuticals ETF Industry Stock Comparison
Sell
44
CNCR
Range Cancer Therapeutics ETF
Last Price:
15.50
Seasonality Move:
-2.75%
Sell
41
FTXH
First Trust Nasdaq Pharmaceuticals ETF
Last Price:
29.46
Seasonality Move:
3.05%
Sell
44
Range Cancer Therapeutics ETF (CNCR)
is a Sell
Is Range Cancer Therapeutics ETF a Buy, Sell or Hold?
- The current Range Cancer Therapeutics ETF [CNCR] share price is $15.69. The Score for CNCR is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
- CNCR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
41
First Trust Nasdaq Pharmaceuticals ETF (FTXH)
is a Sell
Is First Trust Nasdaq Pharmaceuticals ETF a Buy, Sell or Hold?
- The current First Trust Nasdaq Pharmaceuticals ETF [FTXH] share price is $29.30. The Score for FTXH is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
- FTXH is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
CNCR Stock Price Chart
What is Range Cancer Therapeutics ETF's stock price today?
-
The Range Cancer Therapeutics ETF share price today is $15.69
The current trend is moderately bullish and CNCR is experiencing buying pressure, which is a positive indicator for future bullish movement.
FTXH Stock Price Chart
What is First Trust Nasdaq Pharmaceuticals ETF's stock price today?
-
The First Trust Nasdaq Pharmaceuticals ETF share price today is $29.30
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and FTXH is experiencing buying pressure, which is a positive indicator for future bullish movement.
CNCR Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.31 | Buy |
Relative Strength Index (14 RSI): | 58.29 | Buy |
Chaikin Money Flow: | 4125 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (14.57 - 15.57) | Buy |
Bollinger Bands (100): | (13.97 - 15.41) | Buy |
FTXH Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.17 | Buy |
Relative Strength Index (14 RSI): | 55.66 | Buy |
Chaikin Money Flow: | 642 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (28.96 - 29.48) | Buy |
Bollinger Bands (100): | (26.89 - 28.91) | Buy |
CNCR Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 15.64 | Buy |
20-day SMA: | 15.16 | Buy |
50-day SMA: | 14.87 | Buy |
200-day SMA: | 14.75 | Buy |
8-day EMA: | 15.55 | Buy |
20-day EMA: | 15.22 | Buy |
50-day EMA: | 14.9 | Buy |
200-day EMA: | 14.45 | Buy |
FTXH Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 29.27 | Buy |
20-day SMA: | 29.25 | Buy |
50-day SMA: | 28.8 | Buy |
200-day SMA: | 27.47 | Buy |
8-day EMA: | 29.29 | Buy |
20-day EMA: | 29.16 | Buy |
50-day EMA: | 28.74 | Buy |
200-day EMA: | 27.59 | Buy |
Range Cancer Therapeutics ETF Earnings Growth & CNCR Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
First Trust Nasdaq Pharmaceuticals ETF Earnings Growth & FTXH Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Range Cancer Therapeutics ETF Technical Analysis
Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
First Trust Nasdaq Pharmaceuticals ETF Technical Analysis
Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |